REFERENCE
Seruga B, Sterling L, Wang L, Tannock IF.Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials. Journal of Clinical Oncology: 6 Dec 2010. Available from: URL: http://dx.doi.org/10.1200/jco.2010.31.9624
Rights and permissions
About this article
Cite this article
Many serious ADRs of anticancer agents not reported in RCTs. React. Wkly. 1332, 1 (2010). https://doi.org/10.2165/00128415-201013320-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201013320-00001